Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GameStop Corp. (GME) vs Immunovant Inc. Common Stock (IMVT) Price & Performance

GameStop Corp.Trade
Immunovant Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

GameStop Corp. vs Immunovant Inc. Common Stock — how do they compare? GameStop Corp. trades at $25.37 (market cap $12.75B), while Immunovant Inc. Common Stock trades at $30.25 (market cap $6.25B). The key difference: GameStop Corp. is far larger — about 2× Immunovant Inc. Common Stock's market cap, and GameStop Corp. is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 61 Days and Immunovant Inc. Common Stock for 0 Days on average.

GMEIMVT
Market Cap
$12.75B$6.25B
Volume
13,026,9931,755,411
Sector
Consumer CyclicalHealth
52-Week High
$26.53$44.96
52-Week Low
$17.87$17.03
Typical Hold Time
61 Days0 Days
Enterprise Value
$12.03B$5.35B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GameStop Corp.

GME trades at $24.58, down 0.73% on the day, with a bullish technical signal from moving averages and strong insider buying. Revenue declined to $3.82B in 2025, but net income improved to $131.3M with a 25.16% net margin. Recent news highlights CEO Ryan Cohen's aggressive share purchases, fueling positive sentiment.

Outlook hinges on execution of the high-margin collectibles pivot and eBay acquisition potential. Risks include revenue volatility and competitive pressures. Analysts are cautious with 55.55% hold ratings, but insider confidence offers a bullish counter-narrative.

Immunovant Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GME
40% Buy60% Sell
Avg holding period · 61 Days
IMVT
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About GameStop Corp.

Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.

Read more on GME →

About Immunovant Inc. Common Stock

Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.

Read more on IMVT →